TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novo Genetix AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,002
|
429
|
386 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
52
|
-46
|
-36 |
| EBITDA |
52
|
-46
|
-36 |
| Total assets |
271
|
216
|
280 |
| Current assets |
271
|
216
|
280 |
| Current liabilities |
32
|
25
|
40 |
| Equity capital |
206
|
153
|
185 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
70.8%
|
66.1% |
| Turnover per employee |
1,002
|
429
|
386 |
| Profit as a percentage of turnover |
5.2%
|
-10.7%
|
-9.3% |
| Return on assets (ROA) |
19.2%
|
-21.3%
|
-12.9% |
| Current ratio |
846.9%
|
864.0%
|
700% |
| Return on equity (ROE) |
25.2%
|
-30.1%
|
-19.5% |
| Change turnover |
566
|
15
|
-92 |
| Change turnover % |
130%
|
4%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.